Kevin Koch
2012
In 2012, Kevin Koch earned a total compensation of $845.9K as President and Chief Scientific Officer at Array BioPharma, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $59,098 |
|---|---|
| Option Awards | $185,112 |
| Salary | $442,500 |
| Stock Awards | $131,537 |
| Other | $27,700 |
| Total | $845,947 |
Koch received $442.5K in salary, accounting for 52% of the total pay in 2012.
Koch also received $59.1K in non-equity incentive plan, $185.1K in option awards, $131.5K in stock awards and $27.7K in other compensation.
Rankings
In 2012, Kevin Koch's compensation ranked 6,789th out of 11,487 executives tracked by ExecPay. In other words, Koch earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,789 out of 11,487 | 41st |
Division Manufacturing | 2,436 out of 4,253 | 43rd |
Major group Chemicals And Allied Products | 618 out of 1,203 | 49th |
Industry group Drugs | 423 out of 925 | 54th |
Industry Pharmaceutical Preparations | 330 out of 700 | 53rd |
Source: SEC filing on September 13, 2013.
Koch's colleagues
We found three more compensation records of executives who worked with Kevin Koch at Array BioPharma in 2012.